---
document_datetime: 2023-09-21 20:35:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lumoxiti-epar-all-authorised-presentations_en.pdf
document_name: lumoxiti-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.371854
conversion_datetime: 2025-12-19 02:22:24.77029
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
MA (EU) number

(Invented)

Strength name

EU/1/20/1522/001 LUMOXITI 1 mg

EU/1/20/1522/002 LUMOXITI 1 mg

Pharmaceutical

Form

Route of

Administration

Intravenous use

Intravenous use

Immediate

Packaging

Powder: vial

(glass)

Stabiliser: vial

(glass)

Powder: vial

(glass)

Stabiliser: vial

(glass)

Content

(concentration)

Powder: 1 mg Stabiliser: 1 ml

Powder: 1 mg

Stabiliser: 1 ml

Powder for concentrate and solution for solution for infusion Powder for concentrate and solution for solution for infusion Medicinal product no longer authorised

Pack size

2 vials + 1 vial

3 vials + 1 vial